<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2002</study_start_year><condition>Neoplasm Metastasis</condition><condition>Chemotherapy</condition><condition>Colorectal Cancer</condition><condition>Colorectal Neoplasms</condition><condition>Metastatic Cancer</condition><disease>Neoplasm Metastasis</disease><disease>Chemotherapy</disease><disease>Colorectal Cancer</disease><disease>Colorectal Neoplasms</disease><disease>Metastatic Cancer</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2024620</full_dataset_link><location>France</location><study_start_month>7</study_start_month><keyword>Folic Acid</keyword><keyword>Irinotecan</keyword><keyword>Stage IV rectal cancer</keyword><keyword>Oxaliplatin</keyword><keyword>Levoleucovorin</keyword><keyword>Resectable metastases</keyword><keyword>Leucovorin</keyword><keyword>Stage IV colon cancer</keyword><keyword>Adenocarcinoma of the colon</keyword><keyword>Adenocarcinoma of the rectum</keyword><keyword>Fluorouracil</keyword><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>Combination Chemotherapy in Treating Patients With Colorectal Cancer and Resectable Metastases</name><description>PURPOSE: This randomized phase III trial is studying two different combination chemotherapy regimens to compare how well they work in treating patients with colorectal cancer and resectable metastases.</description><dates><creation>2002-07-15</creation></dates><accession>2024620</accession><cross_references><ClinicalTrials___gov>NCT00268398</ClinicalTrials___gov></cross_references></HashMap>